Spex Ltd

Spex Ltd produces a variety of Class I medical devices, primarily focused on patient positioning and support. Examples include the Lateral Trunk Support, designed to assist in clinical settings, and the Spex Wonderseat, which likely aids in patient comfort and stability. The company also offers multiple variations of the Spex device, as well as a specialized product called Spex for Bingo, which appears tailored for specific patient care needs.

Spex Ltd is based in New Zealand. While the company’s devices are classified as Class I in the EU, regulatory compliance depends on the market where they are sold. In the EU, these devices must be listed in EUDAMED, demonstrating adherence to EU Medical Device Regulations (MDR) or the previous Medical Device Directive (MDD). Compliance involves ensuring devices meet EU safety, performance, and labeling requirements, even if the manufacturer is outside the EU.

Yes, Spex Ltd’s devices are listed in the EUDAMED database, which is the official EU registry for medical devices. This matters because EUDAMED provides transparency on device authorizations, certifications, and market surveillance activities. Listing in EUDAMED confirms that the devices have undergone the necessary regulatory processes—such as conformity assessment—to legally enter the EU market, ensuring healthcare providers and regulators can verify compliance with EU standards.

Spex Ltd’s devices are classified as Class I under EU medical device regulations. This classification applies to products posing minimal risk, such as those used for patient positioning or support. Class I devices typically require basic safety and performance requirements to be met, including risk management and labeling obligations. While they undergo regulatory scrutiny, the process is generally less stringent than for higher-risk devices, as they are considered low-risk in clinical use.